Francesca Fornari Selected Research

Francesca Fornari Research Topics

Disease

29	Hepatocellular Carcinoma (Hepatoma) 11/2023 - 07/2007
19	Neoplasms (Cancer) 06/2023 - 07/2007
4	Liver Neoplasms (Liver Cancer) 09/2021 - 09/2012
3	Non-alcoholic Fatty Liver Disease 02/2024 - 08/2014
3	Hypoxia (Hypoxemia) 01/2021 - 06/2010
2	Fibrosis (Cirrhosis) 09/2020 - 03/2019
2	Neoplasm Metastasis (Metastasis) 05/2008 - 09/2007
1	Hypothyroidism 01/2020
1	Inflammation (Inflammations) 09/2016
1	B-Cell Lymphoma (Lymphoma, B Cell) 09/2012
1	Carcinoma (Carcinomatosis) 07/2007

Drug/Important Bio-Agent (IBA)

14	MicroRNAs (MicroRNA)IBA 01/2022 - 07/2007
7	Sorafenib (BAY 43-9006)FDA Link 06/2023 - 07/2017
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2015
3	Cyclin G1IBA 11/2014 - 07/2007
2	atezolizumabIBA 11/2023 - 03/2023
2	Bevacizumab (Avastin)FDA Link 11/2023 - 03/2023
2	Tyrosine Kinase InhibitorsIBA 01/2022 - 01/2022
2	Phosphotransferases (Kinase)IBA 01/2018 - 02/2012
2	Glucose (Dextrose)FDA LinkGeneric 05/2016 - 05/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2014 - 06/2010
2	DNA (Deoxyribonucleic Acid)IBA 02/2014 - 07/2012
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 09/2012 - 08/2012
1	GlycogenIBA 06/2023
1	Aflatoxin B1 (Aflatoxin B)IBA 04/2022
1	DNA AdductsIBA 04/2022
1	CarcinogensIBA 04/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	lenvatinibIBA 01/2022
1	regorafenibIBA 01/2022
1	cabozantinibIBA 01/2022
1	Antineoplastic Agents (Antineoplastics)IBA 09/2021
1	LigandsIBA 01/2021
1	Antiviral Agents (Antivirals)IBA 09/2020
1	Thyroid HormonesIBA 01/2020
1	Triiodothyronine (Liothyronine)FDA LinkGeneric 01/2020
1	Epithelial Cell Adhesion MoleculeIBA 01/2020
1	Cadherins (E-Cadherin)IBA 02/2018
1	CytokinesIBA 09/2016
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 09/2016
1	RNA (Ribonucleic Acid)IBA 08/2014
1	CamptothecinIBA 01/2014
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2014
1	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 09/2012
1	OligonucleotidesIBA 09/2012
1	Proteins (Proteins, Gene)FDA Link 09/2012
1	Cyclin D1IBA 08/2012
1	Complementary DNA (cDNA)IBA 08/2012
1	pyrazoleIBA 02/2012
1	Messenger RNA (mRNA)IBA 04/2010
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 09/2007

Therapy/Procedure

2	Immunotherapy 02/2024 - 01/2022
2	Therapeutics 09/2012 - 04/2010
1	Adjuvant Chemotherapy 05/2008